Movatterモバイル変換


[0]ホーム

URL:


GB9705684D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB9705684D0
GB9705684D0GBGB9705684.0AGB9705684AGB9705684D0GB 9705684 D0GB9705684 D0GB 9705684D0GB 9705684 AGB9705684 AGB 9705684AGB 9705684 D0GB9705684 D0GB 9705684D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9705684.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Novartis AGfiledCriticalCiba Geigy AG
Priority to GBGB9705684.0ApriorityCriticalpatent/GB9705684D0/en
Publication of GB9705684D0publicationCriticalpatent/GB9705684D0/en
Priority to ES01131018Tprioritypatent/ES2270948T3/en
Priority to US09/230,618prioritypatent/US6239124B1/en
Priority to JP50851398Aprioritypatent/JP3942641B2/en
Priority to ES97937526Tprioritypatent/ES2182112T3/en
Priority to SI9730389Tprioritypatent/SI0956034T1/en
Priority to DK01131018Tprioritypatent/DK1208847T3/en
Priority to DE69714861Tprioritypatent/DE69714861T2/en
Priority to AU40124/97Aprioritypatent/AU730781B2/en
Priority to PT97937526Tprioritypatent/PT956034E/en
Priority to SI9730756Tprioritypatent/SI1208847T1/en
Priority to AT97937526Tprioritypatent/ATE222502T1/en
Priority to EP01131018Aprioritypatent/EP1208847B8/en
Priority to AT01131018Tprioritypatent/ATE340586T1/en
Priority to EP97937526Aprioritypatent/EP0956034B1/en
Priority to DE69736750Tprioritypatent/DE69736750T2/en
Priority to PT01131018Tprioritypatent/PT1208847E/en
Priority to CA2261666Aprioritypatent/CA2261666C/en
Priority to NZ333657Aprioritypatent/NZ333657A/en
Priority to PCT/EP1997/004123prioritypatent/WO1998004279A1/en
Priority to DK97937526Tprioritypatent/DK0956034T3/en
Priority to HK00102877Aprioritypatent/HK1023720A1/en
Priority to US09/758,301prioritypatent/US6455518B2/en
Priority to CY0300086Aprioritypatent/CY2391B1/en
Priority to JP2003408898Aprioritypatent/JP4149905B2/en
Pendinglegal-statusCriticalCurrent

Links

GBGB9705684.0A1996-07-301997-03-18Organic compoundsPendingGB9705684D0 (en)

Priority Applications (25)

Application NumberPriority DateFiling DateTitle
GBGB9705684.0AGB9705684D0 (en)1997-03-181997-03-18Organic compounds
DK97937526TDK0956034T3 (en)1996-07-301997-07-29 Pharmaceutical compositions for the treatment of graft rejection, autoimmune or inflammatory conditions comprising cyclosporin A and 40-O- (2-hydroxyethyl) -rapamycin
EP01131018AEP1208847B8 (en)1996-07-301997-07-29Pharmaceutical compositions for the treatment of transplant rejection, as well as autoimmune or inflammatory conditions
EP97937526AEP0956034B1 (en)1996-07-301997-07-29Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxyethyl)-rapamycin
JP50851398AJP3942641B2 (en)1996-07-301997-07-29 Pharmaceutical composition for the treatment of transplant rejection, autoimmune disease or inflammatory condition comprising cyclosporin A and 40-O- (2-hydroxyethyl) -rapamycin
ES97937526TES2182112T3 (en)1996-07-301997-07-29 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF THE REJECTION OF TRANSPLANTS AND OF AUTOIMMUNE OR INFLAMMATORY STATES, THAT INCLUDE CYCLOSPORIN A AND 40-O- (2-HYDROXYETHYL) -RAPAMICINE.
SI9730389TSI0956034T1 (en)1996-07-301997-07-29Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxyethyl)-rapamycin
DK01131018TDK1208847T3 (en)1996-07-301997-07-29 Pharmaceuticals for the treatment of graft rejection as well as autoimmune or inflammatory conditions
DE69714861TDE69714861T2 (en)1996-07-301997-07-29 COMBINATION PRODUCT WITH AN INHIBITING EFFECT ON REPELLATION OF TRANSPLANTS, AUTOIMMUNE DISEASES AND INFLAMMATION, WHICH CONTAINS CYCLOSPORIN A AND 40-0- (2-HYDROXYETHYL) -RAPAMYCIN
AU40124/97AAU730781B2 (en)1996-07-301997-07-29Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin A and 40-0-(2-hydroxiethyl)-rapamycin
PT97937526TPT956034E (en)1996-07-301997-07-29 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TRANSPLANT REJECTION OF INFLAMMATORY OR AUTO-IMMUNE STATES COMPOSING CYCOSPORINE E 40-O- (2-HYDROXYETHYL) -RAPAMICINE
SI9730756TSI1208847T1 (en)1996-07-301997-07-29Pharmaceutical compositions for the treatment of transplant rejection, as well as autoimmune or inflammatory conditions
AT97937526TATE222502T1 (en)1996-07-301997-07-29 COMBINATION PREPARATION WITH AN INHIBITANT EFFECT ON TRANSPLANT REJECTION, AUTOIMMUNE DISEASES AND INFLAMMATION, CONTAINING CYCLOSPORIN A AND 40-0-(2-HYDROXYETHYL)-RAPAMYCIN
ES01131018TES2270948T3 (en)1996-07-301997-07-29 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF REPLACEMENT OF TRANSPLANTS, AS WELL AS THE AUTOIMMUNE OR INFLAMMATORY CONDITIONS.
AT01131018TATE340586T1 (en)1996-07-301997-07-29 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TRANSPLANT REJECTION AND AUTOIMMUNE OR INFLAMMATORY CONDITIONS
US09/230,618US6239124B1 (en)1996-07-301997-07-29Pharmaceutical compositions for the treatment of transplant rejection or autoimmune or inflammatory conditions comprising cyclosporin A and 40-0-(2-hydroxyethyl)-rapamycin
DE69736750TDE69736750T2 (en)1996-07-301997-07-29 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TRANSPLANT DISPOSAL AND AUTOIMMUNE OR INFLAMMABLE CONDITIONS
PT01131018TPT1208847E (en)1996-07-301997-07-29Pharmaceutical compositions for the treatment of transplant rejection, as well as autoimmune or inflammatory conditions
CA2261666ACA2261666C (en)1996-07-301997-07-29Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin
NZ333657ANZ333657A (en)1996-07-301997-07-29A pharmaceutical composition comprising cyclosporin A and 40-O-(2-hydroxyethyl)-rapamycin
PCT/EP1997/004123WO1998004279A1 (en)1996-07-301997-07-29Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin
HK00102877AHK1023720A1 (en)1996-07-302000-05-15Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxyethyl)-rapamycin
US09/758,301US6455518B2 (en)1996-07-302001-01-11Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-O-(2-hydroxyethyl)-rapamycin
CY0300086ACY2391B1 (en)1996-07-302003-11-28Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin.
JP2003408898AJP4149905B2 (en)1996-07-302003-12-08 Pharmaceutical composition for the treatment of transplant rejection, autoimmune disease or inflammatory condition comprising cyclosporin A and 40-O- (2-hydroxyethyl) -rapamycin

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
GBGB9705684.0AGB9705684D0 (en)1997-03-181997-03-18Organic compounds

Publications (1)

Publication NumberPublication Date
GB9705684D0true GB9705684D0 (en)1997-05-07

Family

ID=10809505

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GBGB9705684.0APendingGB9705684D0 (en)1996-07-301997-03-18Organic compounds

Country Status (1)

CountryLink
GB (1)GB9705684D0 (en)

Similar Documents

PublicationPublication DateTitle
GB9713726D0 (en)Organic compounds
GB9711043D0 (en)Organic compounds
GB9700597D0 (en)Organic compounds
GB9703388D0 (en)Organic compounds
GB9705323D0 (en)Organic compounds
GB9700596D0 (en)Organic compounds
GB9700410D0 (en)Organic compounds
GB9704665D0 (en)Organic compounds
GB9708235D0 (en)Organic compounds
GB9706237D0 (en)Organic compounds
GB9709193D0 (en)Organic compounds
GB9703039D0 (en)Organic compounds
GB9703387D0 (en)Organic compounds
GB9704644D0 (en)Organic compounds
GB9704645D0 (en)Organic compounds
GB9704971D0 (en)Organic compounds
GB9705069D0 (en)Organic compounds
GB9705077D0 (en)Organic compounds
GB9702594D0 (en)Organic compounds
GB9706040D0 (en)Organic compounds
GB9706047D0 (en)Organic compounds
GB9706048D0 (en)Organic compounds
GB9706049D0 (en)Organic compounds
GB9706054D0 (en)Organic compounds
GB9701881D0 (en)Organic compounds

[8]ページ先頭

©2009-2025 Movatter.jp